Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10004775
Inhibition of hypoxia-inducible factor activity with carica papaya extracts
granted -
US 10005670
Calcium polyphosphate salt particles and method of making
granted -
US 10005838
Milk fat globule epidermal growth factor 8 regulates fatty acid uptake
granted -
US 10006924
Method for differentially diagnosing ACTH-dependent cushing's syndrome
granted -
US 2018169113
HIGH CONCENTRATION FORMULATION
granted -
US 9999673
PEGylated lipids and their use for drug delivery
granted -
US 10001483
Methods for the treatment of Kaposi's sarcoma or KSHV-induced lymphoma using immunomodulatory compounds, and uses of biomarkers
granted -
US 10000456
Polycyclic compounds as lysophosphatidic acid receptor antagonists
granted -
US 10000551
Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same
granted -
US 10000522
Derivatives of uridine 5′-cyclophosphate useful to treat hepatitis C viral infections
granted -
US 10000582
Ethylsulfonated hyaluronic acid biopolymers and methods of use thereof
granted -
US 10000556
Single-domain VHH antibodies directed to norovirus GI.1 and GII.4 and their use
granted -
US 10000523
β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment
granted -
US 10001485
Methods for sensitizing a quiescent cancer stem cell to a BCR-ABL inhibitor
granted -
US 10001495
Blood factor monitoring assay and uses thereof
granted -
US 10000813
Method of diagnosing and treating cancer using B-catenin splice variants
granted -
US 10000746
LAGLIDADG homing endonuclease cleaving the T cell receptor alpha gene and uses thereof
granted -
US 10000564
Methods of treating an inflammatory condition or sensitivity to an allergen with anti-IL-33 antibodies
granted -
US 10000753
Age-related macular degeneration treatment
granted -
US 10000772
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 10000525
Non-hormonal steroid modulators of NF-κB for treatment of disease
granted -
US 10000534
Peptide having osteoblast proliferation activity and periodontal ligament fibroblast proliferation activity, and use of same
granted -
US 10000488
Heterocyclic compound
granted -
US 10000479
Compounds and their methods of use
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.